Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

8.2K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
8.2K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

927
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
927
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

9.1K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
9.1K
Regulation of Food Intake01:30

Regulation of Food Intake

3.1K
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
3.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

7.8K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.8K
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

5.2K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
5.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Strategies to Improve Cannabidiol Bioavailability and Drug Delivery.

Pharmaceuticals (Basel, Switzerland)·2024
Same author

The therapeutic potential of purified cannabidiol.

Journal of cannabis research·2023
Same author

Cannabinoids and the endocannabinoid system in fibromyalgia: A review of preclinical and clinical research.

Pharmacology & therapeutics·2022
Same author

The Peripheral Cannabinoid Receptor Type 1 (CB<sub>1</sub>) as a Molecular Target for Modulating Body Weight in Man.

Molecules (Basel, Switzerland)·2021
Same author

An Analysis of Over-the-Counter Cannabidiol Products in the United Kingdom.

Cannabis and cannabinoid research·2021
Same author

FABP5 as a novel molecular target in prostate cancer.

Drug discovery today·2020

Related Experiment Video

Updated: Mar 22, 2026

Administration of &#916;9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

1.2K

An update on PPAR activation by cannabinoids.

Saoirse Elizabeth O'Sullivan1

  • 1School of Medicine, Royal Derby Hospital, University of Nottingham.

British Journal of Pharmacology
|April 15, 2016
PubMed
Summary
This summary is machine-generated.

Cannabinoids activate Peroxisome proliferator-activated receptors (PPARs), influencing various physiological effects like pain relief and anti-inflammation. This review explores the extent of PPAR involvement in cannabinoid actions.

More Related Videos

Isolation and Differentiation of Stromal Vascular Cells to Beige/Brite Cells
07:22

Isolation and Differentiation of Stromal Vascular Cells to Beige/Brite Cells

Published on: March 28, 2013

39.6K
Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

802

Related Experiment Videos

Last Updated: Mar 22, 2026

Administration of &#916;9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice
07:51

Administration of Δ9-Tetrahydrocannabinol (THC) in Adolescent and Adult Mice

Published on: August 1, 2025

1.2K
Isolation and Differentiation of Stromal Vascular Cells to Beige/Brite Cells
07:22

Isolation and Differentiation of Stromal Vascular Cells to Beige/Brite Cells

Published on: March 28, 2013

39.6K
Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
05:13

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on: February 28, 2025

802

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Biochemistry

Background:

  • Cannabinoids interact with various biological targets.
  • Peroxisome proliferator-activated receptors (PPARs) are nuclear receptors involved in metabolic and inflammatory processes.
  • The role of PPARs in mediating cannabinoid effects is an area of ongoing research.

Purpose of the Study:

  • To review and update the evidence for cannabinoid activation of PPARs (α, β, and γ).
  • To delineate which physiological responses to cannabinoids are mediated by PPAR activation.
  • To explore the interplay between PPARs and other cannabinoid targets.

Main Methods:

  • Reporter gene assays
  • Binding studies
  • Selective antagonists
  • Knockout studies
  • Literature review

Main Results:

  • Cannabinoids activate PPARα, PPARβ, and PPARγ isoforms.
  • PPARα and PPARγ activation are primarily involved in mediating cannabinoid effects.
  • PPARs mediate some, but not all, of the analgesic, neuroprotective, anti-inflammatory, metabolic, anti-tumour, gastrointestinal, and cardiovascular effects of cannabinoids.
  • PPARs also mediate effects of endocannabinoid degradation inhibitors.
  • Cannabinoid actions are often a result of combined activation of PPARs and other targets like CB1, CB2, and TRPV1.

Conclusions:

  • PPARs are significant targets for certain cannabinoid-mediated physiological effects.
  • Understanding PPAR involvement provides a more comprehensive view of cannabinoid pharmacology.
  • Further research is needed to fully elucidate the mechanisms and therapeutic potential.